INmune Bio Inc’s recently made public that its President and CEO Tesi Raymond Joseph acquired Company’s shares for reported $98048.0 on Sep 12 ’24. In the deal valued at $6.38 per share,15,380 shares were bought. As a result of this transaction, Tesi Raymond Joseph now holds 1,554,106 shares worth roughly $8.11 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Moss David J bought 7,690 shares, generating $49,024 in total proceeds. Upon buying the shares at $6.38, the Chief Financial Officer now owns 1,275,869 shares.
Before that, Juda Scott bought 5,000 shares. INmune Bio Inc shares valued at $36,350 were divested by the Director at a price of $7.27 per share. As a result of the transaction, Juda Scott now holds 71,603 shares, worth roughly $0.37 million.
Raymond James initiated its INmune Bio Inc [INMB] rating to an Outperform in a research note published on September 27, 2024; the price target was $18. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in late August with a ‘”a Sector outperform”‘ rating. Robert W. Baird began covering INMB with “an Outperform” recommendation on June 01, 2023. B. Riley Securities revised its rating on May 24, 2022. It rated INMB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of INMB
On Friday, INmune Bio Inc [NASDAQ:INMB] saw its stock jump 5.24% to $5.22. INmune Bio Inc shares have fallen nearly -53.64% since the year began. Nevertheless, the stocks have fallen -25.53% over the past one year. While a 52-week high of $14.74 was reached on 02/14/24, a 52-week low of $4.81 was recorded on 09/25/24. SMA at 50 days reached $6.76, while 200 days put it at $9.74.
Levels Of Support And Resistance For INMB Stock
The 24-hour chart illustrates a support level at 4.95, which if violated will result in even more drops to 4.68. On the upside, there is a resistance level at 5.62. A further resistance level may holdings at 6.01. The Relative Strength Index (RSI) on the 14-day chart is 38.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.60%. Stochastics %K at 12.10% indicates the stock is a buying.
How much short interest is there in INmune Bio Inc?
A steep rise in short interest was recorded in INmune Bio Inc stocks on 2024-09-13, growing by 0.38 million shares to a total of 3.16 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 2.78 million shares. There was a rise of 12.04%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 07, 2021 when Maxim Group resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $42.
